Cantor Fitzgerald Reiterates Overweight Rating on Crinetics (CRNX) Sep 26, 2025 06:43AM
Cantor Fitzgerald Reiterates Overweight Rating on Crinetics (CRNX) Sep 23, 2025 06:50AM
Crinetics (CRNX) PT Raised to $100 at Cantor Fitzgerald Feb 28, 2025 07:46AM
Crinetics Pharmaceuticals Announces Closing of Underwritten Common Stock Offering Apr 18, 2022 04:01PM
Crinetics Pharmaceuticals Announces Closing of Underwritten Common Stock Offering Apr 18, 2022 04:01PM


Apr 13, 2022 05:39AM Crinetics Pharmaceuticals (CRNX) Prices 5.63M Share Offering at $22.22/sh
Apr 12, 2022 11:50PM Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering
Apr 12, 2022 11:50PM Crinetics Pharmaceuticals Announces Pricing of Underwritten Common Stock Offering
Oct 25, 2021 04:01PM Crinetics Pharmaceuticals Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Oct 25, 2021 04:01PM Crinetics Pharmaceuticals Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Oct 21, 2021 08:23AM Crinetics Pharmaceuticals (CRNX) Prices 7.58M Share Offering of Common Stock at $19.80/sh
Oct 21, 2021 08:22AM Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Oct 21, 2021 08:22AM Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Oct 20, 2021 04:02PM Crinetics Pharmaceuticals (CRNX) Announces Proposed Stock Offering, Size not Disclosed
Oct 20, 2021 04:01PM Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
Oct 20, 2021 04:01PM Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
Sep 7, 2021 07:30AM Crinetics Pharmaceuticals to Participate in September Investor Conferences
Sep 7, 2021 07:30AM Crinetics Pharmaceuticals to Participate in September Investor Conferences
Apr 21, 2021 09:02AM Companies with NDRs 4/21
Apr 19, 2021 06:48AM Companies with NDRs 4/19
Sep 3, 2020 05:56PM Crinetics Pharmaceuticals to Participate in September Investor Conferences
Sep 3, 2020 05:56PM Crinetics Pharmaceuticals to Participate in September Investor Conferences
Apr 17, 2020 04:05PM Crinetics Pharmaceuticals Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Apr 17, 2020 04:05PM Crinetics Pharmaceuticals Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Apr 15, 2020 05:54AM Crinetics Pharmaceuticals (CRNX) Prices 7.15M Share Common Offering at $14/Sh
Apr 15, 2020 12:22AM Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Apr 15, 2020 12:21AM Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Apr 14, 2020 04:06PM Crinetics Pharmaceuticals (CRNX) Announces Proposed Common Share Offering
Apr 14, 2020 04:05PM Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
Apr 14, 2020 04:05PM Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
Mar 12, 2019 07:00AM UPDATE: Cantor Fitzgerald Starts Crinetics (CRNX) at Overweight